タンパク質治療薬の世界市場 2023-2027

当レポートでは、タンパク質治療薬市場をモニターしており、2022年から2027年の間に1,535億6,000万米ドル、予測期間中のCAGRは9.14%で成長すると予測しています。

当レポートでは、タンパク質治療薬市場について、全体的な分析、市場規模と予測、動向、成長促進要因・課題、さらに約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新の動向と促進要因、市場全体の環境に関する最新の分析を提供しています。市場は、mAbの需要拡大、革新的技術を用いた新規治療法の開拓、有利な償還政策の利用可能性によって牽引されています。

本調査では、今後数年間のタンパク質治療薬市場の成長を促進する主な理由の一つとして、製品の改良に注力していることを挙げています。また、オンライン販売の出現と慢性疾患の増加は、市場の大きな需要につながるでしょう。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場別分析
• 市場規模 2022
• 市場の見通し 2022-2027

第4章 市場規模実績

• タンパク質治療薬の世界市場 2017-2021
• 製品セグメント分析 2017-2021
• 用途別分析 2017-2021
• 地域別分析 2017-2021
• 国別分析 2017-2021

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：製品別

• 市場セグメント
• 比較：製品別
• mAb：市場規模と予測 2022-2027
• ヒトインスリン：市場規模と予測 2022-2027
• エリスロポエチン：市場規模と予測 2022-2027
• 凝固因子：市場規模と予測 2022-2027
• その他：市場規模と予測 2022-2027
• 市場機会：製品別

第7章 市場セグメンテーション：用途別

• 市場セグメント
• 比較：用途別
• 代謝障害：市場規模と予測 2022-2027
• 免疫疾患：市場規模と予測 2022-2027
• 血液疾患：市場規模と予測 2022-2027
• がん：市場規模と予測 2022-2027
• 遺伝性疾患：市場規模と予測 2022-2027
• 市場機会：用途別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2022-2027
• 欧州：市場規模と予測 2022-2027
• アジア：市場規模と予測 2022-2027
• 世界のその他の地域：市場規模と予測 2022-2027
• 米国：市場規模と予測 2022-2027
• カナダ：市場規模と予測 2022-2027
• ドイツ：市場規模と予測 2022-2027
• 英国：市場規模と予測 2022-2027
• 中国：市場規模と予測 2022-2027
• 地域情勢別市場機会

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• AbbVie Inc.
• Amgen Inc.
• AstraZeneca Plc
• Biogen Inc.
• Bristol Myers Squibb Co.
• Creative Biolabs
• Eli Lilly and Co.
• F. Hoffmann La Roche Ltd.
• Ipsen Pharma
• Johnson and Johnson Services Inc.
• LGM Pharma LLC
• Novartis AG
• Novo Nordisk AS
• Pfizer Inc.
• Sanofi SA

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Product
• Exhibits6: Executive Summary - Chart on Market Segmentation by Application
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on Global protein therapeutics market 2017 - 2021 ($ billion)
• Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
• Exhibits20: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on Product - Market share 2022-2027 (%)
• Exhibits31: Data Table on Product - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by Product
• Exhibits33: Data Table on Comparison by Product
• Exhibits34: Chart on mAbs - Market size and forecast 2022-2027 ($ billion)
• Exhibits35: Data Table on mAbs - Market size and forecast 2022-2027 ($ billion)
• Exhibits36: Chart on mAbs - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on mAbs - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on Human insulin - Market size and forecast 2022-2027 ($ billion)
• Exhibits39: Data Table on Human insulin - Market size and forecast 2022-2027 ($ billion)
• Exhibits40: Chart on Human insulin - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on Human insulin - Year-over-year growth 2022-2027 (%)
• Exhibits42: Chart on Erythropoeitin - Market size and forecast 2022-2027 ($ billion)
• Exhibits43: Data Table on Erythropoeitin - Market size and forecast 2022-2027 ($ billion)
• Exhibits44: Chart on Erythropoeitin - Year-over-year growth 2022-2027 (%)
• Exhibits45: Data Table on Erythropoeitin - Year-over-year growth 2022-2027 (%)
• Exhibits46: Chart on Clotting factors - Market size and forecast 2022-2027 ($ billion)
• Exhibits47: Data Table on Clotting factors - Market size and forecast 2022-2027 ($ billion)
• Exhibits48: Chart on Clotting factors - Year-over-year growth 2022-2027 (%)
• Exhibits49: Data Table on Clotting factors - Year-over-year growth 2022-2027 (%)
• Exhibits50: Chart on Others - Market size and forecast 2022-2027 ($ billion)
• Exhibits51: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
• Exhibits52: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibits53: Data Table on Others - Year-over-year growth 2022-2027 (%)
• Exhibits54: Market opportunity by Product ($ billion)
• Exhibits55: Data Table on Market opportunity by Product ($ billion)
• Exhibits56: Chart on Application - Market share 2022-2027 (%)
• Exhibits57: Data Table on Application - Market share 2022-2027 (%)
• Exhibits58: Chart on Comparison by Application
• Exhibits59: Data Table on Comparison by Application
• Exhibits60: Chart on Metabolic disorders - Market size and forecast 2022-2027 ($ billion)
• Exhibits61: Data Table on Metabolic disorders - Market size and forecast 2022-2027 ($ billion)
• Exhibits62: Chart on Metabolic disorders - Year-over-year growth 2022-2027 (%)
• Exhibits63: Data Table on Metabolic disorders - Year-over-year growth 2022-2027 (%)
• Exhibits64: Chart on Immunologic disorders - Market size and forecast 2022-2027 ($ billion)
• Exhibits65: Data Table on Immunologic disorders - Market size and forecast 2022-2027 ($ billion)
• Exhibits66: Chart on Immunologic disorders - Year-over-year growth 2022-2027 (%)
• Exhibits67: Data Table on Immunologic disorders - Year-over-year growth 2022-2027 (%)
• Exhibits68: Chart on Hematological disorders - Market size and forecast 2022-2027 ($ billion)
• Exhibits69: Data Table on Hematological disorders - Market size and forecast 2022-2027 ($ billion)
• Exhibits70: Chart on Hematological disorders - Year-over-year growth 2022-2027 (%)
• Exhibits71: Data Table on Hematological disorders - Year-over-year growth 2022-2027 (%)
• Exhibits72: Chart on Cancer - Market size and forecast 2022-2027 ($ billion)
• Exhibits73: Data Table on Cancer - Market size and forecast 2022-2027 ($ billion)
• Exhibits74: Chart on Cancer - Year-over-year growth 2022-2027 (%)
• Exhibits75: Data Table on Cancer - Year-over-year growth 2022-2027 (%)
• Exhibits76: Chart on Genetic disorders - Market size and forecast 2022-2027 ($ billion)
• Exhibits77: Data Table on Genetic disorders - Market size and forecast 2022-2027 ($ billion)
• Exhibits78: Chart on Genetic disorders - Year-over-year growth 2022-2027 (%)
• Exhibits79: Data Table on Genetic disorders - Year-over-year growth 2022-2027 (%)
• Exhibits80: Market opportunity by Application ($ billion)
• Exhibits81: Data Table on Market opportunity by Application ($ billion)
• Exhibits82: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits83: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits84: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits85: Chart on Geographic comparison
• Exhibits86: Data Table on Geographic comparison
• Exhibits87: Chart on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibits88: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibits89: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits90: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits91: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibits92: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibits93: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits94: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits95: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibits96: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibits97: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits98: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits99: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibits100: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibits101: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits102: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits103: Chart on US - Market size and forecast 2022-2027 ($ billion)
• Exhibits104: Data Table on US - Market size and forecast 2022-2027 ($ billion)
• Exhibits105: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits106: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits107: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
• Exhibits108: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
• Exhibits109: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits110: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• Exhibits111: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibits112: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibits113: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits114: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits115: Chart on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibits116: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibits117: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibits118: Data Table on UK - Year-over-year growth 2022-2027 (%)
• Exhibits119: Chart on China - Market size and forecast 2022-2027 ($ billion)
• Exhibits120: Data Table on China - Market size and forecast 2022-2027 ($ billion)
• Exhibits121: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibits122: Data Table on China - Year-over-year growth 2022-2027 (%)
• Exhibits123: Market opportunity By Geographical Landscape ($ billion)
• Exhibits124: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• Exhibits125: Impact of drivers and challenges in 2022 and 2027
• Exhibits126: Overview on Criticality of inputs and Factors of differentiation
• Exhibits127: Overview on factors of disruption
• Exhibits128: Impact of key risks on business
• Exhibits129: Vendors covered
• Exhibits130: Matrix on vendor position and classification
• Exhibits131: AbbVie Inc. - Overview
• Exhibits132: AbbVie Inc. - Product / Service
• Exhibits133: AbbVie Inc. - Key news
• Exhibits134: AbbVie Inc. - Key offerings
• Exhibits135: Amgen Inc. - Overview
• Exhibits136: Amgen Inc. - Product / Service
• Exhibits137: Amgen Inc. - Key offerings
• Exhibits138: AstraZeneca Plc - Overview
• Exhibits139: AstraZeneca Plc - Product / Service
• Exhibits140: AstraZeneca Plc - Key news
• Exhibits141: AstraZeneca Plc - Key offerings
• Exhibits142: Biogen Inc. - Overview
• Exhibits143: Biogen Inc. - Product / Service
• Exhibits144: Biogen Inc. - Key offerings
• Exhibits145: Bristol Myers Squibb Co. - Overview
• Exhibits146: Bristol Myers Squibb Co. - Product / Service
• Exhibits147: Bristol Myers Squibb Co. - Key news
• Exhibits148: Bristol Myers Squibb Co. - Key offerings
• Exhibits149: Creative Biolabs - Overview
• Exhibits150: Creative Biolabs - Product / Service
• Exhibits151: Creative Biolabs - Key offerings
• Exhibits152: Eli Lilly and Co. - Overview
• Exhibits153: Eli Lilly and Co. - Product / Service
• Exhibits154: Eli Lilly and Co. - Key offerings
• Exhibits155: F. Hoffmann La Roche Ltd. - Overview
• Exhibits156: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits157: F. Hoffmann La Roche Ltd. - Key news
• Exhibits158: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits159: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits160: Ipsen Pharma - Overview
• Exhibits161: Ipsen Pharma - Business segments
• Exhibits162: Ipsen Pharma - Key offerings
• Exhibits163: Ipsen Pharma - Segment focus
• Exhibits164: Johnson and Johnson Services Inc. - Overview
• Exhibits165: Johnson and Johnson Services Inc. - Business segments
• Exhibits166: Johnson and Johnson Services Inc. - Key news
• Exhibits167: Johnson and Johnson Services Inc. - Key offerings
• Exhibits168: Johnson and Johnson Services Inc. - Segment focus
• Exhibits169: LGM Pharma LLC - Overview
• Exhibits170: LGM Pharma LLC - Product / Service
• Exhibits171: LGM Pharma LLC - Key offerings
• Exhibits172: Novartis AG - Overview
• Exhibits173: Novartis AG - Business segments
• Exhibits174: Novartis AG - Key offerings
• Exhibits175: Novartis AG - Segment focus
• Exhibits176: Novo Nordisk AS - Overview
• Exhibits177: Novo Nordisk AS - Business segments
• Exhibits178: Novo Nordisk AS - Key offerings
• Exhibits179: Novo Nordisk AS - Segment focus
• Exhibits180: Pfizer Inc. - Overview
• Exhibits181: Pfizer Inc. - Product / Service
• Exhibits182: Pfizer Inc. - Key news
• Exhibits183: Pfizer Inc. - Key offerings
• Exhibits184: Sanofi SA - Overview
• Exhibits185: Sanofi SA - Business segments
• Exhibits186: Sanofi SA - Key news
• Exhibits187: Sanofi SA - Key offerings
• Exhibits188: Sanofi SA - Segment focus
• Exhibits189: Inclusions checklist
• Exhibits190: Exclusions checklist
• Exhibits191: Currency conversion rates for US$
• Exhibits192: Research methodology
• Exhibits193: Validation techniques employed for market sizing
• Exhibits194: Information sources
• Exhibits195: List of abbreviations

Technavio has been monitoring the protein therapeutics market and is forecast to grow by $153.56 bn during 2022-2027, accelerating at a CAGR of 9.14% during the forecast period. Our report on the protein therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased demand for mAbs, the development of novel therapies using innovative technologies, and the availability of favorable reimbursement policies.

Technavio's protein therapeutics market is segmented as below:

By Product

• mAbs
• Human insulin
• Erythropoeitin
• Clotting factors
• Others

By Application

• Metabolic disorders
• Immunologic disorders
• Hematological disorders
• Cancer
• Genetic disorders

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the focus on product improvement as one of the prime reasons driving the protein therapeutics market growth during the next few years. Also, the emergence of online sales and an increase in chronic diseases will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the protein therapeutics market covers the following areas:

• Protein therapeutics market sizing
• Protein therapeutics market forecast
• Protein therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading protein therapeutics market vendors that include AbbVie Inc., Amgen Inc., AstraZeneca Plc, Biocon Ltd., Biogen Inc., Bristol Myers Squibb Co., Celltrion Healthcare Co. Ltd., Creative Biolabs, Eli Lilly and Co., F. Hoffmann La Roche Ltd., Intas Pharmaceuticals Ltd., Ipsen Pharma, Johnson and Johnson Services Inc., LGM Pharma LLC, Midas Pharma GmbH, Novartis AG, Novo Nordisk AS, Pfizer Inc., PV Pharma Healthcare Pvt. Ltd., and Sanofi SA. Also, the protein therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global protein therapeutics market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on Global protein therapeutics market 2017 - 2021 ($ billion)
• 4.2 Product Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
• 4.3 Application Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

• 6.1 Market segments
• Exhibit 30: Chart on Product - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
• 6.2 Comparison by Product
• Exhibit 32: Chart on Comparison by Product
• Exhibit 33: Data Table on Comparison by Product
• 6.3 mAbs - Market size and forecast 2022-2027
• Exhibit 34: Chart on mAbs - Market size and forecast 2022-2027 ($ billion)
• Exhibit 35: Data Table on mAbs - Market size and forecast 2022-2027 ($ billion)
• Exhibit 36: Chart on mAbs - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on mAbs - Year-over-year growth 2022-2027 (%)
• 6.4 Human insulin - Market size and forecast 2022-2027
• Exhibit 38: Chart on Human insulin - Market size and forecast 2022-2027 ($ billion)
• Exhibit 39: Data Table on Human insulin - Market size and forecast 2022-2027 ($ billion)
• Exhibit 40: Chart on Human insulin - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Human insulin - Year-over-year growth 2022-2027 (%)
• 6.5 Erythropoeitin - Market size and forecast 2022-2027
• Exhibit 42: Chart on Erythropoeitin - Market size and forecast 2022-2027 ($ billion)
• Exhibit 43: Data Table on Erythropoeitin - Market size and forecast 2022-2027 ($ billion)
• Exhibit 44: Chart on Erythropoeitin - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Erythropoeitin - Year-over-year growth 2022-2027 (%)
• 6.6 Clotting factors - Market size and forecast 2022-2027
• Exhibit 46: Chart on Clotting factors - Market size and forecast 2022-2027 ($ billion)
• Exhibit 47: Data Table on Clotting factors - Market size and forecast 2022-2027 ($ billion)
• Exhibit 48: Chart on Clotting factors - Year-over-year growth 2022-2027 (%)
• Exhibit 49: Data Table on Clotting factors - Year-over-year growth 2022-2027 (%)
• 6.7 Others - Market size and forecast 2022-2027
• Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ billion)
• Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
• Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
• Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
• 6.8 Market opportunity by Product
• Exhibit 54: Market opportunity by Product ($ billion)
• Exhibit 55: Data Table on Market opportunity by Product ($ billion)

7 Market Segmentation by Application

• 7.1 Market segments
• Exhibit 56: Chart on Application - Market share 2022-2027 (%)
• Exhibit 57: Data Table on Application - Market share 2022-2027 (%)
• 7.2 Comparison by Application
• Exhibit 58: Chart on Comparison by Application
• Exhibit 59: Data Table on Comparison by Application
• 7.3 Metabolic disorders - Market size and forecast 2022-2027
• Exhibit 60: Chart on Metabolic disorders - Market size and forecast 2022-2027 ($ billion)
• Exhibit 61: Data Table on Metabolic disorders - Market size and forecast 2022-2027 ($ billion)
• Exhibit 62: Chart on Metabolic disorders - Year-over-year growth 2022-2027 (%)
• Exhibit 63: Data Table on Metabolic disorders - Year-over-year growth 2022-2027 (%)
• 7.4 Immunologic disorders - Market size and forecast 2022-2027
• Exhibit 64: Chart on Immunologic disorders - Market size and forecast 2022-2027 ($ billion)
• Exhibit 65: Data Table on Immunologic disorders - Market size and forecast 2022-2027 ($ billion)
• Exhibit 66: Chart on Immunologic disorders - Year-over-year growth 2022-2027 (%)
• Exhibit 67: Data Table on Immunologic disorders - Year-over-year growth 2022-2027 (%)
• 7.5 Hematological disorders - Market size and forecast 2022-2027
• Exhibit 68: Chart on Hematological disorders - Market size and forecast 2022-2027 ($ billion)
• Exhibit 69: Data Table on Hematological disorders - Market size and forecast 2022-2027 ($ billion)
• Exhibit 70: Chart on Hematological disorders - Year-over-year growth 2022-2027 (%)
• Exhibit 71: Data Table on Hematological disorders - Year-over-year growth 2022-2027 (%)
• 7.6 Cancer - Market size and forecast 2022-2027
• Exhibit 72: Chart on Cancer - Market size and forecast 2022-2027 ($ billion)
• Exhibit 73: Data Table on Cancer - Market size and forecast 2022-2027 ($ billion)
• Exhibit 74: Chart on Cancer - Year-over-year growth 2022-2027 (%)
• Exhibit 75: Data Table on Cancer - Year-over-year growth 2022-2027 (%)
• 7.7 Genetic disorders - Market size and forecast 2022-2027
• Exhibit 76: Chart on Genetic disorders - Market size and forecast 2022-2027 ($ billion)
• Exhibit 77: Data Table on Genetic disorders - Market size and forecast 2022-2027 ($ billion)
• Exhibit 78: Chart on Genetic disorders - Year-over-year growth 2022-2027 (%)
• Exhibit 79: Data Table on Genetic disorders - Year-over-year growth 2022-2027 (%)
• 7.8 Market opportunity by Application
• Exhibit 80: Market opportunity by Application ($ billion)
• Exhibit 81: Data Table on Market opportunity by Application ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 82: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 83: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibit 84: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 85: Chart on Geographic comparison
• Exhibit 86: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 87: Chart on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibit 88: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibit 89: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 90: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 91: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibit 92: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibit 93: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 94: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 95: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibit 96: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibit 97: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 98: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 99: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibit 100: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibit 101: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 102: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 103: Chart on US - Market size and forecast 2022-2027 ($ billion)
• Exhibit 104: Data Table on US - Market size and forecast 2022-2027 ($ billion)
• Exhibit 105: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 106: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 Canada - Market size and forecast 2022-2027
• Exhibit 107: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
• Exhibit 108: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
• Exhibit 109: Chart on Canada - Year-over-year growth 2022-2027 (%)
• Exhibit 110: Data Table on Canada - Year-over-year growth 2022-2027 (%)
• 9.9 Germany - Market size and forecast 2022-2027
• Exhibit 111: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibit 112: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibit 113: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 114: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.10 UK - Market size and forecast 2022-2027
• Exhibit 115: Chart on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibit 116: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibit 117: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 118: Data Table on UK - Year-over-year growth 2022-2027 (%)
• 9.11 China - Market size and forecast 2022-2027
• Exhibit 119: Chart on China - Market size and forecast 2022-2027 ($ billion)
• Exhibit 120: Data Table on China - Market size and forecast 2022-2027 ($ billion)
• Exhibit 121: Chart on China - Year-over-year growth 2022-2027 (%)
• Exhibit 122: Data Table on China - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 123: Market opportunity By Geographical Landscape ($ billion)
• Exhibit 124: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 125: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 126: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 127: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 128: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 129: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 130: Matrix on vendor position and classification
• 12.3 AbbVie Inc.
• Exhibit 131: AbbVie Inc. - Overview
• Exhibit 132: AbbVie Inc. - Product / Service
• Exhibit 133: AbbVie Inc. - Key news
• Exhibit 134: AbbVie Inc. - Key offerings
• 12.4 Amgen Inc.
• Exhibit 135: Amgen Inc. - Overview
• Exhibit 136: Amgen Inc. - Product / Service
• Exhibit 137: Amgen Inc. - Key offerings
• 12.5 AstraZeneca Plc
• Exhibit 138: AstraZeneca Plc - Overview
• Exhibit 139: AstraZeneca Plc - Product / Service
• Exhibit 140: AstraZeneca Plc - Key news
• Exhibit 141: AstraZeneca Plc - Key offerings
• 12.6 Biogen Inc.
• Exhibit 142: Biogen Inc. - Overview
• Exhibit 143: Biogen Inc. - Product / Service
• Exhibit 144: Biogen Inc. - Key offerings
• 12.7 Bristol Myers Squibb Co.
• Exhibit 145: Bristol Myers Squibb Co. - Overview
• Exhibit 146: Bristol Myers Squibb Co. - Product / Service
• Exhibit 147: Bristol Myers Squibb Co. - Key news
• Exhibit 148: Bristol Myers Squibb Co. - Key offerings
• 12.8 Creative Biolabs
• Exhibit 149: Creative Biolabs - Overview
• Exhibit 150: Creative Biolabs - Product / Service
• Exhibit 151: Creative Biolabs - Key offerings
• 12.9 Eli Lilly and Co.
• Exhibit 152: Eli Lilly and Co. - Overview
• Exhibit 153: Eli Lilly and Co. - Product / Service
• Exhibit 154: Eli Lilly and Co. - Key offerings
• 12.10 F. Hoffmann La Roche Ltd.
• Exhibit 155: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 156: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 157: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 158: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 159: F. Hoffmann La Roche Ltd. - Segment focus
• 12.11 Ipsen Pharma
• Exhibit 160: Ipsen Pharma - Overview
• Exhibit 161: Ipsen Pharma - Business segments
• Exhibit 162: Ipsen Pharma - Key offerings
• Exhibit 163: Ipsen Pharma - Segment focus
• 12.12 Johnson and Johnson Services Inc.
• Exhibit 164: Johnson and Johnson Services Inc. - Overview
• Exhibit 165: Johnson and Johnson Services Inc. - Business segments
• Exhibit 166: Johnson and Johnson Services Inc. - Key news
• Exhibit 167: Johnson and Johnson Services Inc. - Key offerings
• Exhibit 168: Johnson and Johnson Services Inc. - Segment focus
• 12.13 LGM Pharma LLC
• Exhibit 169: LGM Pharma LLC - Overview
• Exhibit 170: LGM Pharma LLC - Product / Service
• Exhibit 171: LGM Pharma LLC - Key offerings
• 12.14 Novartis AG
• Exhibit 172: Novartis AG - Overview
• Exhibit 173: Novartis AG - Business segments
• Exhibit 174: Novartis AG - Key offerings
• Exhibit 175: Novartis AG - Segment focus
• 12.15 Novo Nordisk AS
• Exhibit 176: Novo Nordisk AS - Overview
• Exhibit 177: Novo Nordisk AS - Business segments
• Exhibit 178: Novo Nordisk AS - Key offerings
• Exhibit 179: Novo Nordisk AS - Segment focus
• 12.16 Pfizer Inc.
• Exhibit 180: Pfizer Inc. - Overview
• Exhibit 181: Pfizer Inc. - Product / Service
• Exhibit 182: Pfizer Inc. - Key news
• Exhibit 183: Pfizer Inc. - Key offerings
• 12.17 Sanofi SA
• Exhibit 184: Sanofi SA - Overview
• Exhibit 185: Sanofi SA - Business segments
• Exhibit 186: Sanofi SA - Key news
• Exhibit 187: Sanofi SA - Key offerings
• Exhibit 188: Sanofi SA - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 189: Inclusions checklist
• Exhibit 190: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 191: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 192: Research methodology
• Exhibit 193: Validation techniques employed for market sizing
• Exhibit 194: Information sources
• 13.5 List of abbreviations
• Exhibit 195: List of abbreviations